— Know what they know.
Not Investment Advice
Also trades as: INFI (NASDAQ) · $vol 0M

INFIQ OTC

Infinity Pharmaceuticals, Inc.
1W: -99.0% 1M: -99.0% 3M: +0.0% YTD: -99.0% 1Y: -98.0% 3Y: -100.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
Weekly Expected Move ±9113.7%
$-0 $-0 $0 $0 $0
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 51 · $9076 mcap · 90M float · 0.0075% daily turnover · Short 18% of daily vol

Supply Chain Overview

1 relationships
0
As Filer
counterparties named
1
As Counterparty
mentioned by others
2023-02-23
Earliest Filing
2023-02-23
Latest Filing

Mentioned As Counterparty

1 mentions

Other companies that named INFIQ in their SEC 8-K filings.

Filed By Relationship Summary Filing Date SEC
LITS MEI Pharma, Inc. acquirer Target company in the merger agreement with MEI Pharma, Inc. 2023-02-23 View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms